BRUKER CORP
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BRUKER CORPORATION | ||
| Date: February 29, 2024 | By: | /s/ FRANK H. LAUKIEN, PH.D. |
|---|---|---|
| Name: Frank H. Laukien, Ph.D. | ||
| Title: President, Chief Executive Officer and Chairman | ||
We, the undersigned officers and directors of Bruker Corporation, hereby severally constitute and appoint Frank H. Laukien, Ph.D. to sign for us and in our names in the capacities indicated below, the report on Form 10-K filed herewith and any and all amendments to such report, and to file the same, with all exhibits thereto and other documents in connection therewith, in each case, with the Securities and Exchange Commission, and generally to do all such things in our names and on our behalf in our capacities consistent with the provisions of the Securities Exchange Act of 1934, as amended, and all requirements of the Securities and Exchange Commission.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /S/ FRANK H. LAUKIEN, PH.D. | President, Chief Executive Officer and Chairman (Principal Executive Officer) | February 29, 2024 |
| Frank H. Laukien, Ph.D. | ||
| | | |
| /S/ GERALD N. HERMAN | Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | February 29, 2024 |
| Gerald N. Herman | ||
| /S/ BONNIE H. ANDERSON | Director | February 29, 2024 |
| Bonnie H. Anderson | ||
| /S/ CYNTHIA M. FRIEND, PH.D. | Director | February 29, 2024 |
| Cynthia Friend, Ph.D. | ||
| /S/ WILLIAM A. LINTON | Director | February 29, 2024 |
| William A. Linton | ||
| /S/ Philip Ma | Director | February 29, 2024 |
| Philip Ma | ||
| | | |
| /S/ JOHN ORNELL | Director | February 29, 2024 |
| John Ornell | ||
| /S/ RICHARD A. PACKER | Director | February 29, 2024 |
| Richard A. Packer | ||
| | | |
| /S/ ADELENE Q. PERKINS | Director | February 29, 2024 |
| Adelene Q. Perkins | ||
| /S/ HERMANN REQUARDT, PH.D. | Director | February 29, 2024 |
| Hermann Requardt, Ph.D. | ||
| /S/ ROBERT ROSENTHAL, PH.D. | Director | February 29, 2024 |
| Robert Rosenthal, Ph.D. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.